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Gene expressionTrapping in the endosomes is currently believed to represent the main barrier for transfection. Peptides, which
allow endosomal escape have been demonstrated to overcome this barrier, similarly to the entry of viruses. How-
ever, the design principles of such endosomolytic peptides remain unclear. We characterized three analogs derived
frommembrane disrupting antimicrobial peptides (AMP), viz. LL-37, melittin, and bombolitin V, with glutamic acid
substituting for all basic residues. These analogs are pH-sensitive and cause negligible membrane permeabilization
and insigniﬁcant cytotoxicity at pH7.4. However, at pH5.0, prevailing in endosomes,membrane binding andhemo-
lysis of human erythrocytes become evident. We ﬁrst condensed the emerald green ﬂuorescent protein (emGFP)
containing plasmid by protamine, yielding 115nmdiameter soluble nanoplexes. For coating of thenanoplex surface
with a lipid bilayer we introduced a hydrophobic tether, stearyl-octa-arginine (SR8). The indicated peptides were
dissolved in methanol and combined with lipid mixtures in chloroform, followed by drying at RT under a nitrogen
ﬂow. The dry residues were hydrated with nanoplexes in Hepes, pH 7.4 yielding after a 30 min incubation at RT,
rather monodisperse nanoparticles having an average diameter of 150–300 nm, measured by DLS and cryo-TEM.
Studies with cell cultures showed the above peptides to yield expression levels comparable to those obtained
using Lipofectamine 2000. However, unlike the polydisperse aggregates formed upon mixing Lipofectamine 2000
and plasmid, the procedure described yields soluble, and reasonably monodisperse nanoparticles, which can be
expected to be suitable for gene delivery in vivo, using intravenous injection.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
In order to provide a real therapeutic utility, gene therapy requires an
efﬁcient uptake and insertion of genes into individual cells [1]. Because of
the cytotoxicity and immunogenicity occasionally associated with viraldic LL-37; aMel, acidicmelittin;
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rtment of Chemistry, Universitygene delivery, non-viral vectors continue to be actively developed. Two
currently studied non-viral approaches are i) polyplexes, i.e. complexes
of plasmids and polymers, and ii) lipoplexes, composed of plasmids and
cationic lipids [2,3]. However, the transfection levels achieved so far
have been inferior to those obtained using viruses. Endocytosis is believed
to represent the major cellular route for the uptake of these vectors [4,5],
however, after internalization themajority of plasmids in the above com-
plexes remain within endocytic vesicles [5–7]. Accordingly, there is a
need to developmeans to avoid the entrapment and degradation of plas-
mids in this compartment [6]. For this utility additives such asmembrane
disruptive pH-sensitive peptides, fusogenic lipids, lysosomotropic agents,
‘synthetic’ viruses, toxins, and different polymers have been incorporated
into gene delivery systems [2,6,8–17]. Among these, peptides are gaining
increasing attention because of the ease of their synthesis and introduc-
tion into different gene delivery systems [9,18,19]. Moreover, peptides
are biodegradable, of small size, low cytotoxicity and immunogenicity,
yet able to promote the escape of plasmids from endosomes, similarly
to viruses [9,19–23]. Features such as DNA condensation, membrane
translocation together with cellular and nuclear targeting further empha-
size the potential use of peptides in gene delivery systems [9,17,20].
Several approaches have been used to optimize the amino acid
sequences of cell penetrating peptides to enhance gene delivery by
Table 1
Amino acid sequences of the wild type and modiﬁed AMP.
Peptides Sequences
LL-37 L L G D F F R K S K E K I G K E F K R I V Q R I K D F L R N L V P R T E S
10 20 30
C L L G D F F E E S E E E I G E E F E E I V Q E I E D F L E N L V P E T E S
10 20 30
aLL-37
Melittin G I G A V L K V L T T G L P A L I S W I K R K R Q Q
10 20
C G I G A V L E V L T T G L P A L I S W I E E E E Q Q
10 20
aMel
Bombolitin V I N V L G I L G L L G K A L S H L
10
C I N V L G I L G L L G E A L S E L
10
aBom
Below each sequence is shown the modiﬁed sequence with the introduced substitutions
by Glu underlined and bold.
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Fig. 1. Panel A: Condensation by protamine of the emGFP-Math1 plasmid monitored by
the EtBr displacement assay. Panel B: Sizes of protamine–DNA complexes determined
by DLS with increasing concentrations of protamine sulfate. Both panels depict mean
and standard error for three independent experiments. Panel C: Cryo-TEM images of
protamine–DNA complexes prepared at 1:1 charge ratio (7.4 μg protamine sulfate and
10 μg DNA) (15.15 nmol in base-pairs). Scale bar = 100 nm.
Table 2
Compositions of the nanoplexes given as molar ratios of the indicated peptides and lipids.
Nanoplexes aLL-37 aMel aBom SR8 DOPE eggPC Chol
A 0.1 0.4 0.3 0.2
B 0.015 0.1 0.4 0.285 0.2
C 0.03 0.1 0.4 0.27 0.2
D 0.03 0.1 0.4 0.27 0.2
E 0.03 0.1 0.4 0.27 0.2
545A. Ahmad et al. / Biochimica et Biophysica Acta 1848 (2015) 544–553facilitating endosomal escape [17,20,24–32]. pH-sensitive peptides
were ﬁrst developed and utilized, but their toxicity at physiological
pH 7.4 is restricting their use [30]. A limited number of endosomolytic
peptides have been described in the literature [6,9,24], mostly derived
from viral proteins such as HA2, HA2-TAT, INF7, HGP, H5WYG, GALA,
KALA, and E5WYG [6,8–12,15,18,23,25], in some cases resulting in a
remarkable enhancement of gene expression. Peptides such as
listeriolysin O, diphtheria toxin, exotoxin A, shiga toxin, cholera toxin,
ricin, saporin, gelonin, and melittin were derived from bacteria, plants,
and animals [6,8,13,26]. Also histidine-rich endosomolytic peptides
and imadazole containing biopolymers have been made and character-
ized [20,27–29] for this purpose. However, principles for the design of
endosomolytic peptides and their role in gene expression remain
incompletely understood.
We here report the characterization of endosomolytic peptides
derived from three membrane active antimicrobial peptides (AMP). To
understand the molecular basis of their pH-sensitive cellular toxicity,
we studied their hemolytic activity by the integrity of human red
blood cells (hRBC) assessed by the release of hemoglobin and the
calcein acetoxymethylester (caAM) assay. Transfection of 3T3 cells
by condensed plasmid incorporating nanoparticles containing these
peptides was studied and compared to transfection by the commercial
reagent Lipofectamine 2000.2. Materials and methods
2.1. Materials
Protamine sulfate and caAMwere from Sigma. Stearoyl octaarginine
(SR8) was from Storkbio (Tallin, Estonia). 1,2-Distearoyl-sn-glycero-3-
phosphoethanolamine (DOPE), egg phosphatidylcholine (eggPC), and
cholesterol (Chol), were from Avanti Polar Lipids (Alabaster, AL). The
purity of lipids was checked by thin-layer chromatography on silicic
acid coated plates (Merck, Darmstadt, Germany) developedwith a chlo-
roform/methanol/water mixture (65:25:4, v/v/v). Examination of the
plates after iodine staining revealed no impurities. Lipid concentrations
were determined gravimetrically with a high precision electrobalance
[33]. The emGFP-math1 plasmid pcDNA6.2/C-EmGFP-Math1 [34] was
used as a model for complex preparation and transfection experiments.
Other chemicals were of analytical grade and from standard sources.Table 3
Particle sizes and polydispersities by DLS for the plasmid DNA (pDNA) nanoparticles
before and after the addition of indicated lipids and the peptides (Table 2). The content
of the peptides is expressed in terms of mol% of the total amount of lipids and SR8.
Nanoplexes
(See Table 2)
Peptide added (mol%) Zav diameter PDI
A None, control 194 ± 42.65 0.37 ± 0.12
B aLL-37 (1.5 mol%) 198 ± 10.25 0.39 ± 0.04
C aLL-37 (3 mol%) 927.47 ± 191.9 0.82 ± 0.14
D aMel (3 mol%) 179.9 ± 17.46 0.27 ± 0.003
E aBom (3 mol%) 186.23 ± 42.98 0.4 ± 0.16
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Peptides [Table 1] were purchased from Caslo, Denmark and were
synthesized using standard Fmoc chemistry and puriﬁed by high-
performance liquid chromatography (HPLC) to N97% purity, with
sequences conﬁrmed by mass spectrometry. When indicated these
peptides were labeled at their N-terminal cysteine [35]. In brief, the in-
dicated pH sensitive endosomolytic peptides (pSEP) and rhodamine-Fig. 2.Helical wheel diagrams of AMP and their analogs. The helical wheel projection ﬁgures are
CA at http://rzlab.ucr.edu/scripts/wheel/wheel.cgi). The most hydrophobic residue is green
hydrophobicity coded by yellow. Hydrophilic residues are coded by red with darker red corre
proportionally to the hydrophilicity. For the sake of clarity and easier comparison with the wtmaleimide were incubated at a 1:1.3 M ratio for 3 h in a mixture (1:1,
by vol.) of 100mMHepes, pH7.0 andmethanol at RTwith constant stir-
ring. The resulting conjugates were puriﬁed by HPLC on a C18 reverse
phase column (Amersham Biosciences, Uppsala, Sweden) eluted with
a linear gradient from 20 to 80% acetonitrile in water with 0.1%
triﬂuoroacetic acid at a ﬂow rate of 1 mL/min. Samples weremonitored
for absorbance at 540 nm. Fractions corresponding to the peptide–
rhodamine conjugates were collected and lyophilized.snaphots of Java Applet by Armstrong and Zidovetzki (University of California at Riverside,
with the intensity of color decreasing proportionally to the hydrophobicity, with zero
sponding to more hydrophilic (uncharged) residues, with the intensity of red decreasing
peptides the N-terminal Cys has been omitted from the sequences of the analogs.
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The binding of the rhodamine-labeled pSEP to hRBC at pH 5.0
(150 mM NaCl, 15 mM citric acid) and 7.4 (150 mM NaCl, 20 mM
Hepes) was assessed by ﬂuorescence microscopy (Zeiss LSM-510
METAmicroscopewith a 63×, 1.4NAPlan apochromate (oil immersion)
objective). hRBC were plated on poly-L-Lys-coated slides and incubated
with the indicated rhodamine-labeled pSEP for 30 min in either pH 5.0
or pH 7.4 [36,37], and subsequently ﬁxedwith 2% paraformaldehyde for
15 min and washed extensively with phosphate buffered saline (PBS).
For confocal scanning, slides were mounted in 80% glycerol.
2.4. Assay for hRBC cell membrane integrity
CaAM is non-ﬂuorescent and cell permeable and in live cells
becomes hydrolyzed by intracellular esterases yielding a strongly
ﬂuorescent calcein anion, which is retained in the cytoplasm [38]. Ac-
cordingly, release of caAM can be used to assess e.g. peptide induced
cell membrane permeabilization. For this purpose hRBC (0.6%, v/v in
the indicated buffer) were incubated with 8 μM caAM in PBS for 1 h,
whereafter free caAM and calcein were removed by washing the cells
several times with PBS [38]. hRBC were then resuspended in either
150 mM NaCl, 20 mM Hepes, pH 7.4, or 150 mM NaCl, 15 mM
citric acid, pH 5.0. The indicated peptides were subsequently added
(5, 10, and 15 μM), followed by a 30 min incubation at 37 °C.
Fluorescence intensities for calcein were measured with a Perkin
Elmer spectroﬂuorometer in the timedrive mode using excitation and
emission wavelengths of 490 and 515 nm, respectively [36]. The
percentage of calcein release was calculated from:
% Calcein release ¼ Fp ‐ Fc=Ft‐Fc
h i
 100
where,
Fp ﬂuorescence of sample containing peptide,
Fc ﬂuorescence of sample without peptide, and
Ft ﬂuorescence of sample after the addition of Triton X-100
(0.01% ﬁnal concentration).
2.5. Assay for hemolysis
Fresh hRBC from healthy volunteers were isolated from the blood
collected in the presence of an anticoagulant (heparin) and washed
3–4 times with PBS [10,30,36]. hRBC were suspended at 6% (v/v) in
either pH 7.4, or pH 5.0 buffers in a ﬁnal volume of 200 μL. pSEP dis-
solved in either pH 7.4, or 5.0 buffers as above, were then added. Subse-
quently, after a 30min incubation at 37 °C sampleswere centrifuged forTable 4
Comparison of the wild type and modiﬁed sequences for the presence of aggregating and
amyloid forming sequences predicted by AGGRESCAN and PASTA algorithms.
Peptide AGGRESCAN PASTA
a b c d
LL-37 – −14.4 13–30 −4.25ap
aLL-37 1–5 −20.8 28–33 −3.30p
Melittin 3–13, 15–20 16.0 16–20 −5.03p
aMel 3–14, 16–20 10.4 17–21 −5.03p
Bombolitin V 1–12 41.0 1–7 −6.08p
aBom 1–13 37.2 2–8 −6.08p
a. Aggregation-prone segments (hot spots) predicted by AGGRESCAN.
b. Aggregation score by AGGRESCAN
c. Amyloidogenic regions predicted by PASTA.
d. Free energy calculated by PASTA and relative orientation of neighboringβ-strands in the
ﬁbril core, p = parallel, ap = antiparallel.10min at 2000 rpm, and the release of hemoglobin into the supernatant
was monitored by measuring the supernatant absorbance at 535 nm in
a 96-well microplate reader (SpectraFluor plus, Tecan Gmbh, Salzburg,
Austria) equipped with a 535 nm ﬁlter (10 nm bandpass). For negative
and positive controls, hRBC in PBS (Ablank) and in 0.2% (v/v, ﬁnal concen-
tration) Triton X-100 (Atriton)were used, respectively. The percentage of
hemolysis was calculated as described [36] from:
% hemolysis ¼ Asample‐Ablank
 
= Atriton‐Ablankð Þ
h i
 100:2.6. Plasmid condensation and assembly of nanoplexes
Complexes of the 6093 base-pair emGFP-Math1 plasmid and
protamine sulfate were prepared as described by El-Sayed et al. [23].
Accordingly, 10 μg (corresponding to 15.15 nmol in base-pairs) of the
above plasmid was ﬁrst condensed in 250 μl Hepes buffer, pH 7.4 by
adding 7.4 μg (1.45 nmol) of protamine sulfate to yield a phosphate to
nitrogen ratio of 1:1. Condensation of DNA was monitored by the
ethidium bromide (EtBr) displacement assay [24]. DNA (10 μg) and
EtBr (1 μg) were ﬁrst complexed in a cuvette in 2 mL of 10 mM Hepes
buffer, pH 7.4. Increasing concentrations of protamine sulfate were
then added into this mixture and ﬂuorescence intensity recorded
using a spectroﬂuorometer (Varian eclipse) with excitation and emis-
sion wavelengths of 510 and 595 nm, respectively with the observed
decrease in ﬂuorescence reﬂecting the dissociation of EtBr from the
plasmid (Fig. 1) upon its condensation due to the binding of protamine
sulfate. The solution with the condensed plasmid (0.06 mM base-pairs)
was characterized by dynamic light scattering (DLS, Zetasizer Nano ZS,
Malvern Instruments Ltd., UK) yielding an apparent hydrodynamic
particle diameter (Zav) of 115 nm. Lipids (DOPE, eggPC, and Chol)
were dissolved in chloroform, while SR8 and the indicated peptides
were in methanol. The speciﬁed mixtures (Table 2) were mixed in the
above organic solvents and the latter then evaporated using a gentle
stream of nitrogen, whereafter the dry peptide/lipid residues were
maintained under reduced pressure overnight to remove traces of
solvents. Subsequently, 250 μl of the above nanoplex solution (10 μg
plasmid) was added to hydrate the dry peptide/lipid ﬁlm (75.5 μg
total lipid) for 30 min at RT, followed by a 1 min incubation at RT in a
bath type sonicator. The Zav and polydispersity indexes (PDI) of the
complexes forming after the addition of the indicated pSEP and lipids
(Table 3) were determined at 25 °C by DLS.Fig. 3. Hemolysis of hRBC by aLL-37 (○, ●), aMel (□, ■), and aBom (Δ, ▲) at pH 7.4
(open symbols) and at pH 5.0 (ﬁlled symbols). Each point represents the mean of three
independent experiments with error bars indicating standard deviations.
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NIH 3T3 cells (ATCC, Boras, Sweden) were cultured in Dulbecco's
modiﬁed Eagle's medium (DMEM, Sigma, St Louis, MO, USA)
supplemented with 10% fetal calf serum (FCS) (Invitrogen, USA) and
4mM L-glutamine (SigmaAldrich, USA). One day prior to their transfec-
tion, the cells were trypsinized and replated in 4-well chamber slides
(Lab-Tek®II, Nalge Nunc International, Naperville, USA) at 1.5 × 105
cells per well in 1 mL of fresh FCS-glutamine-DMEM medium.
Nanoplexes were then added to the cells (7.9 μg DNA in 1 mL DMEM)
and incubated for 5 h, whereafter the transfection medium was
replaced with fresh complete medium and the cells were incubated
for another 36 h. Control cells were transfected using the same amount
of the plasmid together with the commercial transfection reagent
Lipofectamine 2000 (Invitrogen, USA), according to the manufacturer's
instructions. After 36 h post-transfection, the cells were washed
three times for 1 min with PBS and ﬁxed with 4% paraformaldehyde
for 30 min. Nuclei were counterstained with 4′, 6-diamidino-2-
phenylindole (DAPI, 10 ng/mL, Sigma-Aldrich, USA) for 10 min and
the cells were thenmountedwith Fluoromount (Sigma, USA) for confo-
cal ﬂuorescence microscopy [34] using a Olympus IX70 microscope
with ANDOR IQ camera and an Ar–Kr laser for excitation at 488 and
568 nm. emGFP emission was recorded using a 525/50 ﬁlter. DAPI
was excited using a 340–380 nm ﬁlter and detected using a 500 nm
long-pass ﬁlter. Cells expressing emGFP were counted as positive
using Image J (http://rsb.info.nih.gov/nih-image) and cells with DAPI
counterstained nuclei were deﬁned as total number of cells (104 cells
were counted). Transfection efﬁciencies were calculated as the percent-
age of emGFP positive cells from the total number of cells.pH= 5.0
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(10 min) and washed extensively with PBS. For confocal imaging slides were mounted in 80%2.8. Assay for cell viability
Viability of NIH 3T3 cells was determined to check for possible
toxicity of the nanoplexes [13,23,30,37]. Accordingly, 104 cells per well
were plated in 96-well plates, followed by an overnight incubation in
a CO2 incubator for adherence. The complete media were discarded
from the plate, and 200 μl incomplete media per well were added.
Concentration of nanoplexes on the basis of their content of DNA was
0.012 mM (1.58 μg DNA in 200 μl). After a 5 h incubation the transfec-
tion media was replaced with fresh complete medium and the cells
were incubated for another 36 h under the same conditions. 20 μL of
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide,
5 mg/mL in PBS) was added to each well. After incubation for 3 h,
media were discarded from the 96-well plates, and 200 μl of dimethyl
sulfoxide (DMSO) was added to each well to dissolve the MTT crystals.
The viability of cells in culture mediumwithout additions was taken as
100%. The plates were measured for absorbance at 550 nm using a
microplate reader.
3. Results
3.1. Design of AMP-derived endosomolytic peptides
Many viruses expose on their surface proteins enriched in acidic
amino acids. Such sequences could be potentially sensitive to pH and
involved in the pH-dependent disruption of endosomal membranes so
as to release the viral genome into the cytoplasm of the target cells,
thus enabling escape from the endosomes [6,8–10,23,30,32,39,40].
Several peptides derived from viral proteins have been shown to havepH=7.4
DIC
aged by confocal microscopy. Rhodamine-labeled peptides, aLL-37, aMel, and aBom were
ges were recorded. hRBC were plated on poly-L-lysine coated slides and incubated with
.4 (150 mM NaCl, 20 mM Hepes). Subsequently, cells were ﬁxed in 2% paraformaldehyde
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Fig. 5. Comparison of calcein release by the three AMP-analogs (each at 5, 10, and 15 μM
concentration), assessed for 8 μM calcein-AM entrapped in hRBC at pH 5.0 (150mMNaCl,
15mMcitric acid, ﬁlled columns) and 7.4 (150mMNaCl, 20mMHepes, hatched columns,
mean and standard error for 3 different experiments performed in triplicates). Calcein
release was signiﬁcant at pH 5.0 for both aLL-37 and aMel. However, aBom showed less
pronounced difference in calcein release at pH 5.0 and 7.4. This could relate to aBom
having at pH 7.0 the smallest net negative charge (−2) due to Glu, in comparison to
aMel (−5) and aLL-37 (-16).
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enriched in glutamic acid (Glu), which could relate to their toxicity at
acidic pH. For example, INF7 is a glutamic acid rich peptide, which
shows signiﬁcant toxicity at pH 5.0, yet negligible toxicity in a similar
concentration at pH 7.0 [23]. Likewise, GALA, which is enriched in acidic
amino acids, shows signiﬁcant and negligible toxic activity at pH 5.0 and
7.0, respectively [11]. Glu is partially protonated at pH 5.0 and this
appears to be sufﬁcient to make these peptides responsive to pH
(10, 11, 30, 40). The above considerations led us to design pH sensitive
peptides from naturally occurring membrane-permeabilizing anti-
microbial peptides. We hypothesized that it could be possible to obtain
pH sensitive endosomolytic peptides from membrane disrupting AMP
by replacing their basic amino acids by Glu. More speciﬁcally, we
chose three well studied AMP, viz. LL-37, melittin, and bombolitin V,
andmodiﬁed these by substituting all basic amino acids for Glu, follow-
ed by the testing of their pH sensitivity and toxicity. Cysteinewas added
at their N terminus to allow for coupling of rhodamine maleimide.
For these peptides, both their amphipathic character as well as hydro-
phobicities remain comparable to the parent peptides (Fig. 2), and all
three analogs reveal amphipathic helices, bothwhen partially protonat-
ed (pH 5.0) and deprotonated (pH 7.0). Furthermore, their propensity
for aggregation and amyloid formation was analyzed by AGGRESCAN
[41] and PASTA [42] algorithms (Table 4) with only a slight reduction
evident in the respective scores, when comparing the acidic peptides
with the native, wild type AMPs. Unfortunately, while it would be ofFig. 6. Cryo-TEM images of nanoplexes, with (Panel Ainterest to see the impact of the protonation of Glu on the
AGGRESCAN and PASTA scores, these algorithms do not allow varying
pH.
The positive charges of AMPs are currently believed to be needed to
target them to acidic phospholipids on the outer surface of microbial
membranes. However, this property is not needed for transfection.
The net negative charge of the modiﬁed peptides would at neutral
pH cause electrostatic repulsion so as to maintain these peptides in a
non-aggregated state while bound to membrane because of their
amphipathic moment, which is retained after the substitution of Glu
for basic residues (Fig. 2). Yet, in keeping with the tendency of these
peptides for self-association, abrogating a fraction of the negative
charges upon protonation of Glu at pH 5.0, abolishes the Coulombic re-
pulsion, allowing subsequent peptide aggregation and permeabilization
of the adjacent endosomal membrane somewhat analogously to the
neutralization of the positive charges of AMPs upon complex formation
with acidic phospholipids [43].
The possibilities for varying the sequences even in these small pep-
tides are prohibitively large. Therefore, we chose to limit the present
study to the above substitution by Glu and refrained from introducing
other changes. Moreover, the aim of this study was to characterize the
designed peptide analogs, somore rigorous testingwas limited to these.
3.2. Characterization of the endosomolytic peptides
Melittin possesses notoriously high cytotoxic activity at both pH 7.4
and 5.0 [10]. LL-37 is a human antimicrobial peptide which shows
negligiblemammalian cell toxicity [44], while bombolitin V exhibits sig-
niﬁcant toxic activity againstmammalian cells [45]. The dose dependent
toxic activities of the designed analogs were tested at pH 7.4 and 5.0 by
the hemolytic assay. The results were further augmented by comparing
the localization by confocal microscopy of Rho-labeled peptides on
hRBCs at pH 5.0 and 7.4 and calcein release at pH 7.4 and 5.0, so as to
support the hemolysis data.
To study the impact of the replacement by Glu on the toxicity
of these AMP and to see if this was sufﬁcient to make these AMPs
pH-sensitive, the hemolytic activities of the above AMP analogs were
assessed at pH 5 and 7.4 using hRBC [30]. Acidic LL-37 (aLL-37) showed
the highest lytic activity at pH 5 and induced at 20 μM concentration
60% cell lysis (Fig. 3). Acidic melittin (aMel) and acidic bombolitin V
(aBom) were slightly less hemolytic than aLL-37 and induced only
20% lysis at 20 μM concentration and at pH 5.0. Notably, at pH 7.4 the
hemolytic activities of the three peptides were very low (Fig. 3).
Binding of the rhodamine-labeled pSEP to hRBC was compared at
pH 5.0 and 7.4 by confocal ﬂuorescence microscopy. Fluorescence of
the labeled pSEP was seen on the surface of hRBC at pH 5.0, in keeping
with the association of pSEP to the cells (Fig. 4). However, at pH 7.4,
the apparent binding of all three ﬂuorescent pSEP onto hRBC was very
weak (Fig. 4). In this context it is worth emphasizing that the ﬂuores-
cence of rhodamine will be enhanced in a non-polar environment,
such as upon entering the membrane hydrocarbon (acyl chain) region,) aMel and (Panel B) aBom. Scale bar = 100 nm.
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in hRBC membranes at pH 5.0, causing permeabilization. Accordingly,
the recorded ﬂuorescence intensities should not be taken as a direct
measure of the amount of peptide bound at pH 5.0 and 7.4.
To assess membrane permeabilization by these three pSEP, release
of entrapped calcein from hRBC was measured at pH 7.4 and 5.0. aLL-
37 (~15 μM) induced a ~82% release of calcein at pH 5.0 (Fig. 5), while
~15 μM aMel and aBom caused at pH 5.0–48% and ~35% calcein release,
respectively. On the other hand, at pH 7.4 all three pSEP induced very
low (~6–7 % for aLL-37 and aMel, and ~19% for aBom) calcein release
(Fig. 5). Dose dependence of calcein release was also assessed at 5 andPlasmid Protamine sulph
Condensation of the
Hydration of lipid films 
mol%; aMel/aBom, 3 m
DNA particles. pSEP are
bilayer. Total lipid:plasm
A
B
Fig. 7. Schematic illustration of the formation of cnDNA–protamine complexes and the subseque
sizes of the molecules are not drawn to scale. Panel A: Schematic illustration of the lipid bilayer
Panel B: Magniﬁed view of the tentative orientation of SR8 attached electrostatically to the DN
attaching the lipid bilayer to the surface of the nanoplex.10 μM peptide concentration (Fig. 5). The above data comply with
hemolysis induced by these pSEP at pH 5.0, and a lack of hemolytic
activity at pH 7.4 (Fig. 3).
3.3. Assembly and characterization of nanoplexes
Protamine sulfate has a high content of arginine and efﬁciently con-
denses DNA already at low concentrations [46,47], as demonstrated
here by the ethidium bromide displacement assay [24], in keeping
with a high afﬁnity binding of protamine to DNA (Fig. 1). Upon ap-
proaching charge neutralization at a ~1:1 nitrogen to phosphate molarate
6093 base-pair plasmid  to form a cnDNA-protamine 
(21:1) complex, Zav ≈115 nm
containing SR8 and the indicated pSEP (aLL-37, 1.5 
ol%, as indicated) to yield lipid coated condensed 
 drawn as amphipathic helices bound to the lipid 
id (base-pairs)= 0.5 mM:0.06 mM
nt addition of lipids, SR8 and pSEP to yield lipid coated nanoplexes. See text for details. The
coated nanoplex, also depicting the anchoring of the bilayer to the stearoyl chains of SR8.
A exposed on the surface of the nanoplex, with the stearoyl chain extending outward and
551A. Ahmad et al. / Biochimica et Biophysica Acta 1848 (2015) 544–553ratio (for protamine/DNA), the average particle sizes were around
~115 nm with PDI of ~0.127, as characterized by DLS, and conﬁrmed
by cryo-transmission electron microscopy (cryo-TEM) (Figs. 1 and 6).
Protamine has been suggested to contain a nuclear localization signal
like amino acid sequence, which could promote the transfer of the
plasmid from cytosol to nucleus [46].
For attaching pSEP to the protamine–DNA complexes the latterwere
ﬁrst coated with a lipid bilayer [23]. To enhance the coating of the
condensed DNA (cnDNA)–protamine complex by a lipid bilayer SR8
was employed to provide a hydrophobic alkyl chain tether on the
surface of the nanoplexes (Fig. 7). SR8 can be expected to compete
with protamine for the negatively charged plasmid on the surface of
the nanoplexes, with its stearyl chain extending from the surface and
representing a hydrophobic anchor for promoting the attachment of a
lipid bilayer (Fig. 7, panel B). The lipid bilayer was necessary in order
to attach the amphipathic pSEP noncovalently to the particle surface
and to eventually protect the plasmid from nucleases. The indicated
pSEP were included in the lipid ﬁlms as described and are expected, be-
cause of their amphipathic character to bind to the lipid bilayer assem-
bling onto the surface of the above nanoplexes. aMel or aBom (3 mol%
with respect to total lipid) was included into the nanoplexes. However,
this content of aLL-37 induced particle aggregation. Accordingly, only
1.5 mol% of aLL-37 was used (Table 3). Compositions of the nanoplexes
are summarized in Table 2. The nanoplexes containing the above pep-
tides had average sizes between 150 and 300 nm, as determined by
DLS and cryo-TEM (Fig. 6). The nanoplexes were stable after one week
at 4 ○C from their preparation with DLS revealing no changes in Zav.
3.4. Enhancement of transfection by pSEP
The expression of the plasmid contained in the lipid coated
nanoplexes with and without pSEP was measured using 3T3 cells.
Nanoplexes without pSEP transfected only ~1.8% of the cells while the
commercial reagent Lipofectamine 2000 transfected ~11.9%. Inclusion
of pSEP into nanoplexes increased emGFP expression signiﬁcantly,
with aLL-37, aMel, or aBom containing nanoplexes yielding transfection
levels of ~9.2, ~7.6 and ~10.8%, respectively (Figs. 8 and 9). Nanoplexes
with a higher content of aLL-37 (3mol%) had low transfection efﬁciency
(data not shown) and large aggregates were seen by DLS.
The viability of 3T3 cells exposed to nanoplexes both without and
with pSEP was examined using the MTT assay, demonstrating lack of
effect on cell viability by the pSEP containing nanoplexes (Fig. 10).Control
aLL-37 aBom
aMel
Fig. 8. Confocal ﬂuorescence microscopy images of emGFP expression in 3T3 cells after the add
aMel, and aBom as indicated. Cells transfected by nanoplexes without pSEP are shown as a
commercial reagent Lipofectamine 2000. Scale bar = 100 μm.Lipofectamine was not included as control because of its well known
lack of toxicity seen in routine use for the transfection of cultured
cells. Moreover, the chemical composition of Lipofectamine is proprie-
tary, which would not allow for a meaningful molecular level interpre-
tation of the data.
4. Discussion
The preparation of monodisperse nanoparticles with uniform
size, shape and composition has been intensively pursued because of
potentially allowing administration by i.v. injection. The major advan-
tage of soluble monodisperse nanoparticles is that they should be able
to pass through capillaries without causing thrombus formation and
obstructing blood circulation so as to cause tissue infarct. Along these
lines these particles should also be accessible for adding proper
targeting ligands to achieve more cell speciﬁc responses [48] Instead,
polydisperse aggregates obtained using Lipofectamine are not suitable
for i.v. injection. Yet, they work very well with cell cultures, as these
aggregates sediment and concentrate on the surface of cultured cells
yielding efﬁcient uptake.
A growing body of evidence suggests that lipid based delivery
vectors represent a promising approach to practical gene therapy
because of low toxicity, biodegradability, high cellular uptake, and
easy surface functionalization by both covalent and non-covalent
strategies [2,3,34]. However, this approach has been limited by poor
gene delivery into the cytosol because of insufﬁcient endosomal escape
[2,3,6]. The addition of endosomolytic peptides has been shown to po-
tentially remedy the latter and enhance gene expression by promoting
gene transfer into the cytosol [9,23,31,32]. In this study we describe
the design of three pH-sensitive peptides (aLL-37, aMel, and aBom)
(Table 1), obtained by replacing the positively charged amino acids
in their sequences with Glu. Confocal ﬂuorescence microscopy demon-
strated that rhodamine-labeled pSEP bind to hRBC at endosomal pH 5.0,
with negligible ﬂuorescence at pH 7.4 (Fig. 4). Likewise, these pSEP have
high lytic activity against hRBC at pH= 5.0, with insigniﬁcant lysis seen
at pH 7.4 (Fig. 3). Calcein release showed that all three pSEP induced
signiﬁcant hRBC membrane disruption at pH 5.0 and had a negligible
effect at 7.4, (Fig. 5). The above data demonstrate pH-sensitivity of the
membrane interaction of these peptides, in agreement with previous
studies which have shown peptides containing negatively charged
amino acids to have endosomolytic activity at acidic pH [10,11,30].
Overall, our results demonstrate that these pSEP permeabilize theLipofectamine 2000
ition of pSEP containing nanoplexes with compositions compiled in Table 3, with aLL-37,
control. For comparison transfection is illustrated with the same plasmid but using the
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Fig. 9. Percentage of 3T3 cell transfected by the nanoplexes with the indicated pSEP,
quantitated by emGFPﬂuorescence using image J software, illustratingmean and standard
error for two different experiments. Control: Nanoplexes without pSEP, nanoplexes
containing the indicated peptides aLL-37, aMel, and aBom. For comparison data is
shown for cells transfected by the same plasmid and Lipofectamine 2000.
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endosomes at themoderately acidic pH of approx. 5.0 of the endosomes.
[10,11,39,40].
Both Asp and Glu make peptides sensitive to pH [10,11,30] and sev-
eral viruses contain surface proteins which are enriched in these resi-
dues. Both bear a net negative charge at pH of 7.4, and become
partially protonated at pH = 5.0 [10,11,30,40]. Several endosomolytic
agents have been designed to become protonated at endosomal pH
of 5.0. [8,10,11,23,27–30,39,40] and are thus expected to destabilize
the endosomal membrane, causing the escape of viruses from
endosomes [10,11,39,40]. In a similar fashion, because of themembrane
permeabilization of these AMPs these pSEP derived from AMPwith Glu
substituted for Lys and Arg should become membrane disrupting
at endosomal pH. Protonation of Glu abrogates Coulombic repulsion
between the membrane associated peptides and allows peptide aggre-
gation, which has been concluded to be involved in membrane perme-
abilization [43].
Following endocytosis of the particles pSEP allows endosomal es-
cape by breaking the endosomal membrane at acidic pH, resulting in
the release of the nucleocapsid-like cnDNA protamine nanoparticles
into the cytosol. The transfection efﬁciency of our nanoparticles was
tested in 3T3 cells. Characterized by DLS (Table 3) and cryo-TEM
(Fig. 6) the sizes of nanoplexes were 150–300 nm. The MTT assay for0
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Fig. 10. Viability of 3T3 cells assessed by the MTT assay after the addition of nanoplexes
containing the indicated peptides (means ± S.D. for ﬁve independent experiments).
Blank: cell culture without nanoplexes, Control: nanoplexes without pSEP.3T3 cells exposed to the nanoplexes bothwith or without pSEP, showed
no loss of cell viability (Fig. 10).
The endocytic pathway is one of the main cellular uptake mecha-
nism for most nanoparticles. Eventually, the material taken up by this
mechanism becomes enclosed in a low pH environment of endosomes
for degradation by the contained hydrolytic enzymes. We included
into the nanoplexes peptides derived from AMP in order to augment
gene expression by promoting gene delivery into the cytosol [Table 3].
Gene expression was visualized by confocal microscopy and quantiﬁed
by analysis using image J. Our pSEP added to nanoplexes resulted
in the transfection of 8–11%of cultured cells (Figs. 8, 9), at levels compa-
rable to the transfection efﬁciency achieved using the commercial trans-
fection reagent Lipofectamine 2000. Higher contents (3mol%) of aLL-37
attenuated the expression of the reporter gene (data not shown), prob-
ably because of aggregation of nanoplexes [49] while both (3 mol%)
aMel and aBom yielded signiﬁcant transfection efﬁciencies correspond-
ing to the levels observed using 1.5 mol% aLL-37.
Accumulating data suggest that pH-induced endosomal membrane
destabilization as employed by viruses may be involved in the action
of synthetic anionic peptides used to enhance gene delivery [6,9–11,
15,23,25,31,32,39,40]. This process is likely to underlie also the action
of the endosomolytic peptides described here. These pSEP had apprecia-
ble membrane disruptive activity at pH 5.0 and are expected to utilize
this property to promote the degradation of the endosomal membrane,
thus promoting the entry of the nanoplexes into the cytoplasm. Our
ﬁndings support the notion that modiﬁcation of lipid nanoparticles
with endosomolytic peptides by covalent or non-covalent strategy can
be employed to obtain endosomal escape and elevated levels of gene
expression. The non-viral pSEP modiﬁed lipid based nanocarriers de-
scribed here are efﬁcient, yet show no evidence for toxicity, presumably
delivering the containedDNA into cells by amechanism resembling that
used by viruses.
It is relevant to keep the limitations of our strategy in mind, while
making it clear that ample possibilities remain available for the design
of novel functional peptides for improving gene transfer. Our present
study should be considered just a small step towards establishing
rational design principles for achieving more efﬁcient peptides to aug-
ment transfection. Along these lines, our approach is simply focused
on overcoming the endosomal trapping of DNA as a barrier for gene
delivery. Much more work remains to be done to achieve synthetic
virus-like particles conveying genes to speciﬁc cells in an efﬁcient, safe
manner.
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